PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
1 Year Est. Return
+40.86%
AUM
$610M
AUM Growth
+$126M
(+26%)
Holding
54
Top Buys
| 1 | +$46.8M | |
| 2 | +$42.7M | |
| 3 | +$20M | |
| 4 |
Alkermes
ALKS
|
+$15.9M |
| 5 |
Procept Biorobotics
PRCT
|
+$15.9M |
Top Sells
| 1 | +$20M | |
| 2 | +$16.4M | |
| 3 | +$15.4M | |
| 4 |
Roivant Sciences
ROIV
|
+$11.5M |
| 5 |
Avantor
AVTR
|
+$10.3M |
Sector Composition
| 1 | Healthcare | 99.84% |
| 2 | Industrials | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
BridgeBio Pharma
BBIO
$13B
| – | – |
-30,000
|
|
||
52
CareDx
CDNA
$1.18B
| – | – |
-250,000
|
|
||
|
FOLD
53
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-1,150,000
|
|
||
54
Icon
ICLR
$10.4B
| – | – |
-110,000
|
|